D Munguia

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Long-Acting Therapy of Viral Retinitis with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl) cytosine

Marisa Flores Aguilar, Jiun‐Yan Huang, G. A. Wiley et al. · The Journal of Infectious Diseases · 1994 · 43 citations

Vaccination, Viral Retinitis, Viral Persistence +12

An Animal Model for Cidofovir (HPMPC) Toxicity: Intraocular Pressure and Histopathologic Effects

İbrahim Taşkintuna, Alay Banker, N A Rao et al. · Experimental Eye Research · 1997 · 32 citations

Ocular Disease, Intraocular Pressure, Ophthalmology +7

Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.

Douglas Dolnak, D Munguia, Clayton A. Wiley et al. · PubMed · 1992 · 30 citations

Ocular Disease, Vitreous Body, Electron Microscopy +12

Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMP.

SIMA SHAKIBA, Kerry K. Assil, Alan Listhaus et al. · PubMed · 1993 · 14 citations